Insiders Trades

★ Sign in to follow

ST

Sean Tucker

Board Director

Director

US·SEC (Form 4)

Cumul. flow

Total declarations

15

Company

1

▲ Purchases (0 ops.)

—

▼ Sales (1 ops.)

€36k

Latest filing published 31 Mar 2026 for Vaxart, Inc., €2,211. Read the official filing

Filing timeline

BuySale

Sean Tucker

Insider track record

Disclosed buys

0

Disclosed sells

1

Not enough buy signals with a settled T+90 horizon to measure a track record yet.

Signal history

Sean Tucker: trading record in brief

Sean Tucker (board member) discloses dealings in Vaxart, Inc. to SEC (Form 4). We count 15 filings; the first trade dates from 10 August 2021 and the latest from 28 March 2026.

No open-market purchase appears, only 1 sale worth €36k. Besides market trades, the filings include 13 share grants and 1 option exercise.

The record was last updated on 31 March 2026 with a share grant (€2,211) in Vaxart, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. For comparison, the SEC allows two business days to file a Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.

Companies and markets linked to Sean Tucker

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Vaxart, Inc. (US)

Declarations15 total

◆

SVP, Chief Scientific OfficerExecutives28 Mar 2026Vaxart, Inc.

2,551 USD11SEC ↗

3,924 shares@ US$0.652.1% of flowCommon StockSEC:0001437749-26-010709:0

◆

SVP, Chief Scientific OfficerExecutives24 Mar 2026Vaxart, Inc.

25,274 USD13SEC ↗

36,418 shares@ US$0.69420.2% of flowCommon StockSEC:0001437749-26-009966:0

◆

SVP, Chief Scientific OfficerExecutives18 Mar 2026Vaxart, Inc.

5,122 USD11SEC ↗

8,072 shares@ US$0.63464.0% of flowCommon StockSEC:0001437749-26-009205:0

◆

SVP, Chief Scientific OfficerExecutives16 Mar 2026Vaxart, Inc.

200,000 shares0Common StockSEC:0001437749-26-008909:0

◆

SVP, Chief Scientific OfficerExecutives2 Feb 2026Vaxart, Inc.

5,638 USD11SEC ↗

9,265 shares@ US$0.60854.1% of flowCommon StockSEC:0001437749-26-003253:0

◆

SVP, Chief Scientific OfficerExecutives28 Mar 2025Vaxart, Inc.

1,648 USD11SEC ↗

3,913 shares@ US$0.42121.3% of flowCommon StockSEC:0001437749-25-010486:0

◆

SVP, Chief Scientific OfficerExecutives24 Mar 2025Vaxart, Inc.

406,000 shares0Common StockSEC:0001437749-25-009451:0

◆

SVP, Chief Scientific OfficerExecutives18 Mar 2025Vaxart, Inc.

4,590 USD11SEC ↗

8,050 shares@ US$0.57023.5% of flowCommon StockSEC:0001437749-25-008650:0

◆

SVP, Chief Scientific OfficerExecutives2 Feb 2025Vaxart, Inc.

6,283 USD12SEC ↗

9,242 shares@ US$0.67985.0% of flowCommon StockSEC:0001437749-25-002803:0

◆

SVP, Chief Scientific OfficerExecutives28 Mar 2024Vaxart, Inc.

5,073 USD11SEC ↗

3,902 shares@ US$1.303.9% of flowCommon StockSEC:0001437749-24-010475:0

◆

SVP, Chief Scientific OfficerExecutives28 Mar 2023Vaxart, Inc.

2,762 USD11SEC ↗

3,683 shares@ US$0.752.1% of flowCommon StockSEC:0001437749-24-008753:0

◆

SVP, Chief Scientific OfficerExecutives17 Mar 2023Vaxart, Inc.

45,000 shares0Common StockSEC:0001437749-23-007440:0

◇

SVP, Chief Scientific OfficerExecutives22 Apr 2022Vaxart, Inc.

30,800 USD13SEC ↗

40,000 shares@ US$0.7724.3% of flowCommon StockSEC:0001437749-22-009651:0

◆

SVP, Chief Scientific OfficerExecutives28 Mar 2022Vaxart, Inc.

43,750 shares0Common StockSEC:0001437749-22-007738:0

▼

SVP, Chief Scientific OfficerExecutives10 Aug 2021Vaxart, Inc.

42,554 USD14SEC ↗

4,172 shares@ US$10.2031.0% of flowCommon StockSEC:0001437749-21-019515:0

15 of 15 declarations